CH611282A5 - - Google Patents

Info

Publication number
CH611282A5
CH611282A5 CH497878A CH497878A CH611282A5 CH 611282 A5 CH611282 A5 CH 611282A5 CH 497878 A CH497878 A CH 497878A CH 497878 A CH497878 A CH 497878A CH 611282 A5 CH611282 A5 CH 611282A5
Authority
CH
Switzerland
Application number
CH497878A
Inventor
Michiro Inoue
Masayuki Ishikawa
Takashi Tsuchiya
Takio Shimamoto
Original Assignee
Michiro Inoue
Masayuki Ishikawa
Takashi Tsuchiya
Takio Shimamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12126073A external-priority patent/JPS5732065B2/ja
Priority claimed from JP12175773A external-priority patent/JPS5724786B2/ja
Application filed by Michiro Inoue, Masayuki Ishikawa, Takashi Tsuchiya, Takio Shimamoto filed Critical Michiro Inoue
Publication of CH611282A5 publication Critical patent/CH611282A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH497878A 1973-10-30 1974-10-30 CH611282A5 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12126073A JPS5732065B2 (en:Method) 1973-10-30 1973-10-30
JP12175773A JPS5724786B2 (en:Method) 1973-10-31 1973-10-31

Publications (1)

Publication Number Publication Date
CH611282A5 true CH611282A5 (en:Method) 1979-05-31

Family

ID=26458679

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1454674A CH610892A5 (en:Method) 1973-10-30 1974-10-30
CH497878A CH611282A5 (en:Method) 1973-10-30 1974-10-30

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1454674A CH610892A5 (en:Method) 1973-10-30 1974-10-30

Country Status (20)

Country Link
US (1) US3963716A (en:Method)
AR (1) AR205004A1 (en:Method)
CA (1) CA1029377A (en:Method)
CH (2) CH610892A5 (en:Method)
DD (1) DD119231A5 (en:Method)
DE (1) DE2451417C3 (en:Method)
DK (1) DK134345B (en:Method)
ES (1) ES431454A1 (en:Method)
FI (1) FI59402C (en:Method)
FR (1) FR2248841B1 (en:Method)
GB (1) GB1459606A (en:Method)
HU (1) HU168797B (en:Method)
IE (1) IE39831B1 (en:Method)
IL (1) IL45675A (en:Method)
IN (1) IN139552B (en:Method)
LU (1) LU71191A1 (en:Method)
NL (1) NL7414186A (en:Method)
PH (1) PH10519A (en:Method)
SE (1) SE412389B (en:Method)
YU (1) YU289774A (en:Method)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120960A (en) * 1973-10-31 1978-10-17 The Boots Company Limited Therapeutic agents
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4464532A (en) * 1979-07-31 1984-08-07 Nippon Kayaku Kabushiki Kaisha Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
JPS5668609A (en) * 1979-11-07 1981-06-09 Nippon Kayaku Co Ltd Phthalazinol preparation
JPS58116471A (ja) * 1981-12-29 1983-07-11 Nippon Kayaku Co Ltd 4−ヒドロキシメチル−1−フタラゾンエステル誘導体およびその塩
GB2127805A (en) * 1982-09-13 1984-04-18 Showa Denko Kk Phthalazones
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
CA1334969C (en) * 1988-08-19 1995-03-28 Mark James Suto Substituted dihydroisoquinoline and phthalazine derivatives as potentiators of the lethal effects of radiation and certain chemotherapeutic agents, selected compounds, analogs andprocess
US5177075A (en) * 1988-08-19 1993-01-05 Warner-Lambert Company Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
DE4333761A1 (de) * 1993-10-04 1995-04-06 Luitpold Pharma Gmbh Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
RU2169139C1 (ru) * 2000-08-02 2001-06-20 Закрытое акционерное общество "Центр современной медицины "Медикор" Способ получения щелочных и щелочноземельных солей 5-амино-2,3-дигидро-1,4-фталазиндиона
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9492422B2 (en) 2009-11-13 2016-11-15 Toray Industries, Inc. Therapeutic or prophylactic agent for diabetes
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2012223337C1 (en) 2011-03-01 2016-11-10 Bausch Health Ireland Limited Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
MX375926B (es) 2013-08-09 2025-03-07 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116430B2 (en:Method) * 1971-08-05 1976-05-24
US3870792A (en) * 1972-07-24 1975-03-11 Michiro Inoue Certain dihydrophthalizines for treating hemorrhage and thrombosis

Also Published As

Publication number Publication date
IE39831B1 (en) 1979-01-03
YU289774A (en) 1983-01-21
SE7413530L (en:Method) 1975-05-02
PH10519A (en) 1977-05-26
DE2451417A1 (de) 1975-05-07
IL45675A0 (en) 1974-11-29
FI59402B (fi) 1981-04-30
FI315774A7 (en:Method) 1975-05-01
FR2248841A1 (en:Method) 1975-05-23
IL45675A (en) 1978-10-31
NL7414186A (nl) 1975-05-02
FR2248841B1 (en:Method) 1978-07-28
AU7295474A (en) 1976-03-11
DE2451417B2 (de) 1980-05-14
DE2451417C3 (de) 1981-01-29
ES431454A1 (es) 1976-10-16
GB1459606A (en) 1976-12-22
US3963716A (en) 1976-06-15
DK134345C (en:Method) 1977-03-21
IN139552B (en:Method) 1976-07-03
IE39831L (en) 1975-04-30
SE412389B (sv) 1980-03-03
AR205004A1 (es) 1976-03-31
DD119231A5 (en:Method) 1976-04-12
CA1029377A (en) 1978-04-11
CH610892A5 (en:Method) 1979-05-15
DK134345B (da) 1976-10-25
HU168797B (en:Method) 1976-07-28
LU71191A1 (en:Method) 1975-04-17
DK561874A (en:Method) 1975-07-07
FI59402C (fi) 1981-08-10

Similar Documents

Publication Publication Date Title
AR201758A1 (en:Method)
AU465372B2 (en:Method)
AR201235Q (en:Method)
AR201231Q (en:Method)
AU474511B2 (en:Method)
FR2248841B1 (en:Method)
AU471343B2 (en:Method)
AU465453B2 (en:Method)
AU465434B2 (en:Method)
AU450229B2 (en:Method)
AR201229Q (en:Method)
AU466283B2 (en:Method)
AR199451A1 (en:Method)
AU472848B2 (en:Method)
AR195948A1 (en:Method)
AR197627A1 (en:Method)
AR200256A1 (en:Method)
AR200885A1 (en:Method)
AR201432A1 (en:Method)
AU461342B2 (en:Method)
AU471461B2 (en:Method)
AU447540B2 (en:Method)
AR210729A1 (en:Method)
AU1891376A (en:Method)
AR196123Q (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased